TrialThe Journal of clinical endocrinology and metabolism2013

Efficacy and safety of insulin degludec in a flexible dosing regimen vs insulin glargine in patients with type 1 diabetes (BEGIN: Flex T1): a 26-week randomized, treat-to-target trial with a 26-week extension.

Chantal Mathieu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.